| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &General Counsel | SVP &General Counsel
1 company
Jimenez Freddy A. is a SVP &General Counsel at Celldex Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | CLDX Celldex Therapeutics, Inc. | SVP &General Counsel | Sell | 4,166 | $29.10 | $121,209.77 | -11.9% | -0.3% | - | |
| Aug 13, 2025 | CLDX Celldex Therapeutics, Inc. | SVP &General Counsel | Sell | 771 | $24.77 | $19,095.91 | -1.1% | -2.5% | - | |
| Jun 3, 2024 | CLDX Celldex Therapeutics, Inc. | SVP &General Counsel | Sale+OE | 8,006 | $33.60 | $269,002.40 | -23.6% | +24.0% | -40.6% | |
| Aug 11, 2021 | CLDX Celldex Therapeutics, Inc. | SVP &General Counsel | Buy | 430 | $46.28 | $19,900.40 | New | +6.1% | -20.2% |